Amir Dan Rubin, renowned for his transformative leadership at One Medical, where he spearheaded its $4 billion acquisition by Amazon in 2023, will headline the event.
NEW YORK, Sept. 4, 2024 /PRNewswire/ — Hyro announces the return of Digital Front Door Day, a premier virtual summit dedicated to building the new digital front door and revolutionizing healthcare access and delivery. Set to take place on September 25th, 2024, this year’s event promises to be a landmark gathering for healthcare professionals and tech innovators, headlined by Amir Dan Rubin, former CEO of One Medical and Stanford Health Care and the current CEO and Founding Managing Partner of Healthier Capital.
Meet Our Headliner
Amir Dan Rubin, renowned for his transformative leadership at One Medical, where he spearheaded its $4 billion acquisition by Amazon in 2023, will headline the event. Rubin’s visionary approach to healthcare innovation has set new standards in patient-centered care and digital health solutions.
Other distinguished keynote speakers include:
Event Highlights
“Digital Front Door Day is not just an event; it’s a movement towards more accessible and efficient healthcare for all,” said Israel Krush, Hyro’s CEO and Co-Founder. “We are excited to have Amir and the rest of this stellar lineup of keynote speakers bring their wealth of experience and insight to our audience.
Join the brightest stars in healthcare innovation to connect, discuss, and build the new Digital Front Door. Register for the summit for free: https://www.hyro.ai/events/dfdd-2024/
For any questions about the summit, please contact: liat@hyro.ai
Hyro, the leading Responsible AI-Powered Communications Platform for healthcare, enables healthcare providers and payers to safely automate workflows and conversations across their most valuable platforms, services, and channels—including call centers, websites, SMS, mobile apps, and more. Hyro’s clients, which include Intermountain Health, Baptist Health, and EmblemHealth, benefit from AI assistants that are fully HIPAA-compliant, fast to deploy, easy to maintain, and simple to scale—generating better conversations, successful patient outcomes, and revenue-driving insights.
This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.
SOURCE Hyro
As a leader in neuroscience, Teva is committed to researching new treatment innovations that may…
As a leader in neuroscience, Teva remains committed to helping address unmet needs in the…
Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment…
MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (OTC: SMFL) (“Smart for…
SAN FRANCISCO, Sept. 20, 2024 /PRNewswire/ -- The Global Ultrasound Institute (GUSI) is proud to…
Toronto, Ontario--(Newsfile Corp. - September 20, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the…